NPPA exempts Biodeal Pharma's antiepileptic nasal spray from DPCO price control for five years: Gireesh Babu, New Delhi Tuesday, November 10, 2026, 08:00 Hrs [IST] The National Ph ...

Allergy specialists submit an application to have a treatment approved for use in Guernsey.

On November 6, 2026, during the ninth China International Import Expo (CIIE) in Shanghai, BD, a global American medical ...

VapoLung, a respiratory wellness oral spray for adults, enters the U.S. market with its full Supplement Facts panel, ...

If you have frequent sinus symptoms that follow a seasonal pattern, allergies may be the root cause. Seasonal allergies can ...

Research highlights the role of nasal health in childhood ear infections, making nasal hygiene as important as oral ...

The National Association of Pharmacy Regulatory Authorities (NAPRA) classified Neffy as a Schedule II product across Canada, ...

Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, announced today that its Board of ...

A prospective, multicenter, noninterventional study conducted across Thailand, Taiwan, Malaysia, and Hong Kong has ...

ALK-Abelló Pharmaceuticals Inc. Canada (ALK Canada) today announced that the National Association of Pharmacy Regulatory Authorities (NAPRA) classified neffy® (epinephrine nasal spray) 2 mg as a ...

Johnson & Johnson led a $100M investment in a psychedelic-inspired biotech, signaling strategic interest in neuroscience ...